These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23138315)

  • 1. [Novel therapeutic approach to neuropathic pain: "Hot" and "Cool" TRP-channel family].
    Kamei T; Miyauchi M; Oyamada Y; Shimizu I
    Nihon Yakurigaku Zasshi; 2012 Nov; 140(5):196-200. PubMed ID: 23138315
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient receptor potential channels as therapeutic targets.
    Moran MM; McAlexander MA; Bíró T; Szallasi A
    Nat Rev Drug Discov; 2011 Aug; 10(8):601-20. PubMed ID: 21804597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient Receptor Potential Channels in neuropathic pain.
    Basso L; Altier C
    Curr Opin Pharmacol; 2017 Feb; 32():9-15. PubMed ID: 27835802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
    Sałat K; Filipek B
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.
    Morera E; De Petrocellis L; Morera L; Moriello AS; Nalli M; Di Marzo V; Ortar G
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1674-7. PubMed ID: 22257892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient receptor potential ion channels: powerful regulators of cell function.
    Billeter AT; Hellmann JL; Bhatnagar A; Polk HC
    Ann Surg; 2014 Feb; 259(2):229-35. PubMed ID: 23989052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borneol inhibits TRPA1, a proinflammatory and noxious pain-sensing cation channel.
    Sherkheli MA; Schreiner B; Haq R; Werner M; Hatt H
    Pak J Pharm Sci; 2015 Jul; 28(4):1357-63. PubMed ID: 26142526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TRP channels for pain relief: A review of current evidence from bench to bedside.
    Koivisto AP; Voets T; Iadarola MJ; Szallasi A
    Curr Opin Pharmacol; 2024 Apr; 75():102447. PubMed ID: 38471384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity.
    Eid SR; Crown ED; Moore EL; Liang HA; Choong KC; Dima S; Henze DA; Kane SA; Urban MO
    Mol Pain; 2008 Oct; 4():48. PubMed ID: 18954467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
    Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of transient receptor potential (TRP) channels by Chinese herbal extracts.
    Zhang Y; Sreekrishna K; Lin Y; Huang L; Eickhoff D; Degenhardt C; Xu T
    Phytother Res; 2011 Nov; 25(11):1666-70. PubMed ID: 21432926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRPA1 channel in inflammatory and neuropathic pain and migraine.
    Nassini R; Materazzi S; Benemei S; Geppetti P
    Rev Physiol Biochem Pharmacol; 2014; 167():1-43. PubMed ID: 24668446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thermosensitive TRP channels and brain function].
    Tominaga M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Apr; 36(2):37-41. PubMed ID: 27333657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation and regulation of nociceptive transient receptor potential (TRP) channels, TRPV1 and TRPA1].
    Tominaga M
    Yakugaku Zasshi; 2010 Mar; 130(3):289-94. PubMed ID: 20190512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of natural compound carnosol as a novel TRPA1 receptor agonist.
    Zhai C; Liu Q; Zhang Y; Wang S; Zhang Y; Li S; Qiao Y
    Molecules; 2014 Nov; 19(11):18733-46. PubMed ID: 25405290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is TRPA1
    Giorgi S; Nikolaeva-Koleva M; Alarcón-Alarcón D; Butrón L; González-Rodríguez S
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity.
    Miyano K; Minami K; Yokoyama T; Ohbuchi K; Yamaguchi T; Murakami S; Shiraishi S; Yamamoto M; Matoba M; Uezono Y
    Anesth Analg; 2015 Apr; 120(4):790-8. PubMed ID: 25642661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
    Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRP channels: potential drug target for neuropathic pain.
    Marwaha L; Bansal Y; Singh R; Saroj P; Bhandari R; Kuhad A
    Inflammopharmacology; 2016 Dec; 24(6):305-317. PubMed ID: 27757589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: Involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors.
    Horváth Á; Tékus V; Bencze N; Szentes N; Scheich B; Bölcskei K; Szőke É; Mócsai A; Tóth-Sarudy É; Mátyus P; Pintér E; Helyes Z
    Pharmacol Res; 2018 May; 131():231-243. PubMed ID: 29438782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.